Cita APA

Huh, W. K., Brady, W. E., Fracasso, P. M., Dizon, D. S., Powell, M. A., Monk, B. J., . . . Aghajanian, C. (2020). Phase II Study of Axalimogene Filolisbac (ADXS-HPV) for Platinum-Refractory Cervical Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol.

Chicago Style Citation

Huh, Warner K., et al. "Phase II Study of Axalimogene Filolisbac (ADXS-HPV) for Platinum-Refractory Cervical Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2020.

Cita MLA

Huh, Warner K., et al. "Phase II Study of Axalimogene Filolisbac (ADXS-HPV) for Platinum-Refractory Cervical Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2020.